Testing a new pain drug in surgery patients at risk for opioid dependence
Treatments studied
Part of Pain clinical trials.
This trial tests a new painkiller called suzetrigine for post-surgery pain. It's designed for people whose medical records suggest they may have a higher chance of needing strong painkillers (opioids) long after surgery. We want to see if suzetrigine works better at preventing that.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- You are having a major surgery (like hip, knee, shoulder replacement, spine surgery, breast surgery, gynecologic surgery, or abdominal surgery).
- Your medical history before surgery suggests you may be at higher risk for long-term opioid use (we check this with a special computer model).
- You are able to understand and agree to the study.
- You are not pregnant, not in prison, and you have not had problems with opioids in the past.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new pain medication called suzetrigine to see how well it reduces pain after ureteroscopy, a common procedure for kidney stones. If you are having this surgery, you may be able to join and get a treatment that could help you manage pain with fewer side effects.
This study tests an investigational pain medicine called suzetrigine to see how well it controls pain after total hip replacement surgery. It is for adults 18–80 who are having a first-time hip replacement and can receive spinal anesthesia.
This study tests whether a new pain medication called suzetrigine can help you recover comfortably after a cesarean delivery without needing strong opioid painkillers. You'll receive the study drug and complete follow-up check-ins for two weeks after surgery.
This trial tests a new pain medication, suzetrigine, for people having breast surgery (not mastectomy) who are expected to have moderate pain. It checks if this drug works well compared to standard options.
This study tests whether a new pain medication called suzetrigine can reduce the need for opioids (strong painkillers) after vaginal pelvic reconstructive surgery. The goal is to manage post-surgery pain safely with fewer opioids.
This trial tests a new medicine, suzetrigine, for managing acute pain in adults who have broken three or more ribs from a blunt injury. It aims to see if this painkiller works well and is safe for you.
Hear when a new Opioid Consumption, Postoperative trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.